C-mo System 1.0's Validation - Cough Monitoring

Launched by COUGH MONITORING MEDICAL SOLUTIONS · Aug 4, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new device called the C-mo System, which is designed to monitor and analyze coughs in patients with respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and other related issues. Coughing is a common symptom that can provide important information about a person's health, but it is often difficult for patients to describe their cough accurately. The C-mo System includes a wearable device that tracks cough frequency, intensity, and type, as well as identifies patterns related to coughing. This information can help doctors diagnose conditions more quickly and effectively, manage treatments, and monitor how diseases progress over time.

To participate in this trial, you must be at least 2 years old and have a cough. If you are 18 years or older, you can give your own consent to join, while younger participants will need consent from a parent or guardian. The trial is currently recruiting participants and aims to validate the C-mo System in a diverse group of patients. By taking part, you will help researchers understand how this device can improve care for people with cough-related health issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 2 years or older;
• • Patients with symptoms/complaints of cough;
• • Signed Informed Consent (age ≥ 18 years), signed Informed Consent from the parents/legal representative and the patient (16 and 17 years), or signed Informed Assent and Consent (5 years ≤ age ≤ 15 years).
• Exclusion Criteria:
• • Presence of musculoskeletal (e.g., severe scoliosis), neurological (e.g., post stroke), cardiac (e.g., unstable angina), cognitive (e.g., dementia) changes, or other significant conditions that hinder the participants from collaborating in the collection of data.
• • Damaged/weakened skin at the C-mo wearable device's placement area (epigastric region).
• • Absence of Informed Consent and/or Assent, as applicable.